Fifth Third Bancorp’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $103K | Sell |
819
-237
| -22% | -$29.8K | ﹤0.01% | 1148 |
|
2025
Q1 | $117K | Buy |
1,056
+254
| +32% | +$28.1K | ﹤0.01% | 1096 |
|
2024
Q4 | $109K | Sell |
802
-2
| -0.2% | -$273 | ﹤0.01% | 1120 |
|
2024
Q3 | $92.6K | Buy |
804
+88
| +12% | +$10.1K | ﹤0.01% | 1204 |
|
2024
Q2 | $98.6K | Buy |
716
+92
| +15% | +$12.7K | ﹤0.01% | 1150 |
|
2024
Q1 | $86.1K | Buy |
624
+32
| +5% | +$4.41K | ﹤0.01% | 1168 |
|
2023
Q4 | $78K | Sell |
592
-30
| -5% | -$3.95K | ﹤0.01% | 1221 |
|
2023
Q3 | $70K | Buy |
622
+211
| +51% | +$23.7K | ﹤0.01% | 1244 |
|
2023
Q2 | $38.8K | Buy |
411
+62
| +18% | +$5.85K | ﹤0.01% | 1464 |
|
2023
Q1 | $35.3K | Buy |
349
+48
| +16% | +$4.86K | ﹤0.01% | 1590 |
|
2022
Q4 | $36K | Sell |
301
-15
| -5% | -$1.79K | ﹤0.01% | 1472 |
|
2022
Q3 | $34K | Sell |
316
-103
| -25% | -$11.1K | ﹤0.01% | 1478 |
|
2022
Q2 | $41K | Buy |
419
+102
| +32% | +$9.98K | ﹤0.01% | 1447 |
|
2022
Q1 | $30K | Buy |
317
+69
| +28% | +$6.53K | ﹤0.01% | 1658 |
|
2021
Q4 | $21K | Hold |
248
| – | – | ﹤0.01% | 1844 |
|
2021
Q3 | $24K | Buy |
248
+238
| +2,380% | +$23K | ﹤0.01% | 1731 |
|
2021
Q2 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 2389 |
|
2020
Q2 | – | Sell |
-104
| Closed | -$9K | – | 2183 |
|
2020
Q1 | $9K | Sell |
104
-18
| -15% | -$1.56K | ﹤0.01% | 1749 |
|
2019
Q4 | $13K | Buy |
122
+18
| +17% | +$1.92K | ﹤0.01% | 1777 |
|
2019
Q3 | $9K | Sell |
104
-896
| -90% | -$77.5K | ﹤0.01% | 1821 |
|
2019
Q2 | $84K | Hold |
1,000
| – | – | ﹤0.01% | 1184 |
|
2019
Q1 | $88K | Buy |
1,000
+999
| +99,900% | +$87.9K | ﹤0.01% | 1104 |
|
2018
Q4 | $0 | Sell |
1
-88
| -99% | – | ﹤0.01% | 2305 |
|
2018
Q3 | $11K | Sell |
89
-77
| -46% | -$9.52K | ﹤0.01% | 1803 |
|
2018
Q2 | $16K | Hold |
166
| – | – | ﹤0.01% | 1742 |
|
2018
Q1 | $14K | Sell |
166
-176
| -51% | -$14.8K | ﹤0.01% | 1795 |
|
2017
Q4 | $27K | Sell |
342
-392
| -53% | -$30.9K | ﹤0.01% | 1493 |
|
2017
Q3 | $45K | Sell |
734
-225
| -23% | -$13.8K | ﹤0.01% | 1321 |
|
2017
Q2 | $44K | Buy |
959
+52
| +6% | +$2.39K | ﹤0.01% | 1317 |
|
2017
Q1 | $39K | Buy |
+907
| New | +$39K | ﹤0.01% | 1389 |
|
2016
Q4 | – | Sell |
-499
| Closed | -$25K | – | 2251 |
|
2016
Q3 | $25K | Sell |
499
-3,507
| -88% | -$176K | ﹤0.01% | 1557 |
|
2016
Q2 | $182K | Sell |
4,006
-1,031
| -20% | -$46.8K | ﹤0.01% | 940 |
|
2016
Q1 | $199K | Sell |
5,037
-31
| -0.6% | -$1.23K | ﹤0.01% | 919 |
|
2015
Q4 | $287K | Buy |
5,068
+3,864
| +321% | +$219K | ﹤0.01% | 859 |
|
2015
Q3 | $48K | Sell |
1,204
-1,357
| -53% | -$54.1K | ﹤0.01% | 1418 |
|
2015
Q2 | $122K | Sell |
2,561
-85
| -3% | -$4.05K | ﹤0.01% | 1134 |
|
2015
Q1 | $105K | Buy |
+2,646
| New | +$105K | ﹤0.01% | 1180 |
|